Founding partner. Chief Executive Officer
Phone: +46 8 5600 2002
Prior to starting Sofus in 2002, Linda was Director Regulatory Affairs at Galderma Nordic and before that Head of Regulatory Affairs at Meda AB. Linda holds a BSc Pharm from Uppsala University and a MSc Tox from The Karolinska Institute
Founding Partner. Chief Financial Officer
Phone: +46 8 5600 2001
Staffan holds a BSc in Economics from Stockholm University. Prior to founding Sofus, Staffan was in executive positions within marketing, sales and business development with Meda and with Novartis and Ciba-Geigy.
Partner. Director Regulatory Affairs – Local Markets
Phone: +46 8 5600 2003
Hanna is Director for Sofus Regulatory Affairs – Local markets services. She holds a BSc Pharm and joined Sofus from a position as Regulatory Affairs Officer at Sanofi-Synthélabo. Employed since 2005.
Partner. Director Regulatory Intelligence
Phone: +46 8 5600 2024
Lovisa hold a BSc Molecular Cell Biology and joined Sofus from a position at the European Medicines Agency in London. She is Director of Regulatory Intelligence. Employed since 2011.
Partner. Director Quality and Compliance Services
Phone: +46 8 5600 2029
Maria is Director for Sofus Quality and Compliance Services. Maria holds a MSc Biology and an U.C Chemical Engineering and came to us from GSK Sweden where she, for several years, held the position of Head of Regulatory Affairs, including responsibility for QA and Safety operations.
Employed since 2013.
Partner. Director Head Office Regulatory Affairs
Phone: +46 8 5600 2021
Rolf is Director Head Office Regulatory Services. He holds a PhD in Biomedicine and joined Sofus in 2009.
Director Development Regulatory Affairs
Phone: +46 8 5600 2008
Erik has a MSc Pharmacy, a MSc Economics and Business Administration and a PhD in Medicinal Chemistry. He joined Sofus from a position as a chemical and pharmaceutical assessor at the Medical Products Agency, Sweden where he participated at scientific advice and assessed MAA as well post-approval variations in different procedures and different therapeutic areas.
At Sofus he specialises in areas related to drug development and regulatory CMC. He is involved in various regulatory development projects where he provides strategic and operational regulatory guidance, author and review CMC documents and support clinical trials. His area of expertise also includes due diligence and technology transfers.